Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0923620130130050177
Immune Network
2013 Volume.13 No. 5 p.177 ~ p.183
Nanoparticle-Based Vaccine Delivery for Cancer Immunotherapy
Park Yeong-Min

Lee Seung-Jun
Kim Young-Seob
Lee Moon-Hee
Cha Gil-Sun
Jung In-Duk
Kang Tae-Heung
Han Hee-Dong
Abstract
Development of nano-sized carriers including nanoparticles, nanoemulsions or liposomes holds great potential for ad-vanced delivery systems for cancer immunotherapy, as such nanostructures can be used to more effectively manipulate or deliver immunologically active components to specific target sites. Successful development of nanotechnology based platform in the field of immunotherapy will allow the applica-tion of vaccines, adjuvants and immunomodulatory drugs that improve clinical outcomes for immunological diseases. Here, we review current nanoparticle-based platforms in the efficacious delivery of vaccines in cancer immunotherapy.
KEYWORD
Nanoparticle, Cancer, Vaccine, Immunotherapy
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø